Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel
2011

ARHI Re-expression Induces Autophagy in Breast Cancer Cells and Enhances Paclitaxel Effects

publication Evidence: moderate

Author Information

Author(s): Zou Chun-Fang, Jia Luoqi, Jin Hongyan, Yao Ming, Zhao Naiqing, Huan Jin, Lu Zhen, Bast Robert C Jr, Feng Youji, Yu Yinhua

Primary Institution: Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University

Hypothesis

Does re-expression of ARHI induce autophagy in breast cancer cells and enhance the effects of paclitaxel?

Conclusion

Re-expression of ARHI induces autophagic cell death in breast cancer cells and enhances the inhibitory effects of paclitaxel.

Supporting Evidence

  • ARHI re-expression was shown to induce autophagy in breast cancer cells.
  • Paclitaxel alone did not induce autophagy but enhanced ARHI-induced autophagy.
  • ARHI re-expression promoted apoptosis and G2/M cell cycle arrest in breast cancer cells.
  • Combination treatment with ARHI and paclitaxel significantly inhibited tumor growth in xenograft models.

Takeaway

ARHI is a gene that helps fight breast cancer by making cancer cells die and work better with a drug called paclitaxel.

Methodology

ARHI was re-expressed in breast cancer cells using transfection and drug treatments, and the effects were evaluated in cell cultures and xenograft models.

Limitations

The study primarily focused on specific breast cancer cell lines and may not generalize to all breast cancer types.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2407-11-22

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication